Does Epitalon actually lengthen telomeres in humans?

Telomere lengthening was shown in cultured human cells and telomerase activation in lab models. There is no rigorous controlled human trial demonstrating meaningful telomere or lifespan effects in living people.

Where does the human evidence come from?

Most human-relevant claims trace to observational cohort reports and reviews from a single Russian research group (Khavinson and colleagues), which have methodological limitations by modern trial standards.

Is Epitalon proven to extend human lifespan?

No. Lifespan extension has been reported in mice, flies and other models, but this has not been established in controlled human studies.

Is Epitalon known to be safe?

There are no controlled human safety trials meeting Western standards. Animal data suggest low acute toxicity, but long-term human safety, including any theoretical risk tied to telomerase activation, is not established.

Research chemical — not approvedaka Epithalon, AEDG peptide

Epitalon — Complete Research Guide (2026)

Last updated 2026-06-25

TL;DR

A synthetic tetrapeptide (Ala-Glu-Asp-Gly) studied in Russian research for effects on the pineal gland and telomerase; human evidence is limited.

What is Epitalon?

Epitalon (also spelled Epithalon; AEDG, Ala-Glu-Asp-Gly) is a synthetic tetrapeptide modeled on the pineal preparation epithalamin, developed by Vladimir Khavinson's group at the St. Petersburg Institute of Bioregulation and Gerontology. It is a research chemical only, not approved by the FDA, EMA, or any major regulator for any indication, and it is not a recognized medicine.

The bulk of the published evidence is preclinical (Russian rodent, cell-culture, and geroprotection work), and much of the human signal comes from older observational cohort reports by a single research group, so claims should be read with caution.

How does Epitalon work?

In cell and animal studies Epitalon is reported to upregulate the telomerase catalytic subunit (hTERT), lengthen telomeres in telomerase-negative human cells, and modulate pineal/melatonin and antioxidant pathways.

These are proposed mechanisms from laboratory models, not established mechanisms of a clinical anti-aging effect in humans. [INFOGRAPHIC: Epitalon telomerase activation in cell models]

What does the research say about Epitalon?

In cultured human fibroblasts, Epitalon reactivated telomerase and elongated telomeres, an in-vitro molecular finding, not a demonstrated anti-aging outcome in people. ^[1]
In female mice, lifelong Epitalon dosing increased maximum lifespan (~12%) and reduced spontaneous tumor incidence, indicating geroprotective activity in a rodent model. ^[2]
In vitro, Epitalon reduced post-ovulatory aging-related oxidative damage in mouse oocytes, a cell-protection effect in an animal-gamete model only. ^[3]

Clinical research & studies

The references below are the primary sources cited throughout this guide. Each links directly to PubMed or the regulator. Where evidence is preclinical (animal or in-vitro), that is stated rather than implied.

[1] Epithalon peptide induces telomerase activity and telomere elongation in human somatic cells — Khavinson VKh et al., Bull Exp Biol Med 2003. (in-vitro (human cells))
[2] Effect of Epitalon on biomarkers of aging, life span and spontaneous tumor incidence in female Swiss-derived SHR mice — Anisimov VN et al., Biogerontology 2003. (animal (mice))
[3] Epitalon protects against post-ovulatory aging-related damage of mouse oocytes in vitro — Yue X et al., Aging (Albany NY) 2022. (animal / in-vitro)
[4] Overview of Epitalon-Highly Bioactive Pineal Tetrapeptide with Promising Properties — Araj SK et al., Int J Mol Sci 2025. (review)
[5] Peptides and Ageing — Khavinson VKh, Neuro Endocrinol Lett 2002. (review)

Dosing context

This is not medical advice or a usage recommendation. Dosing figures are reported research context only, cited from the published literature.

Published protocols describing injectable Epitalon regimens derive from animal experiments and from non-controlled human observational reports, not from validated clinical dose-finding trials.

There is no established, evidence-based human dose, and this material is for research context only, not a dosing recommendation.

Side effects & safety profile

There are no rigorous, controlled, peer-reviewed human safety trials of synthetic Epitalon that meet Western regulatory standards; the human safety reassurances in the literature come largely from older observational Russian cohort reports and reviews by the originating research group.

Animal studies report low acute toxicity, but that does not establish long-term human safety, and any effect on telomerase raises theoretical questions (e.g., proliferative/oncologic signaling) that remain unresolved.

No validated human pharmacokinetic profile or half-life is established, and this content does not endorse human use.

Stacking & combinations

In the research literature Epitalon is sometimes discussed alongside other Khavinson bioregulator peptides, but no controlled human study validates any combination for efficacy or safety.

Finding Epitalon vendors

This is an independent, neutral directory — we sell nothing and route no purchases. Use it to read regulatory context and (where available) genuine, moderated vendor information for your country.

Choose your country

We never list placeholder vendors. Pick your country to see neutral regulatory context.

Browse the directory

User reviews

No reviews yet

Reviews appear here once submitted and moderated. An aggregate rating is shown only after at least 5 genuine reviews — we never fabricate ratings.

Frequently asked questions

No. Epitalon is not approved by the FDA, EMA, or other major regulators for any use. It is sold and discussed only as a research chemical.

References

[1] Epithalon peptide induces telomerase activity and telomere elongation in human somatic cells — Khavinson VKh et al., Bull Exp Biol Med 2003. PMID: 12937682. View sourceStudy: in-vitro (human cells)Epithalon reactivated telomerase (hTERT) and lengthened telomeres in telomerase-negative human fetal fibroblasts.
[2] Effect of Epitalon on biomarkers of aging, life span and spontaneous tumor incidence in female Swiss-derived SHR mice — Anisimov VN et al., Biogerontology 2003. PMID: 14501183. View sourceStudy: animal (mice)Chronic Epitalon dosing increased maximum lifespan and lowered spontaneous tumor incidence in female mice.
[3] Epitalon protects against post-ovulatory aging-related damage of mouse oocytes in vitro — Yue X et al., Aging (Albany NY) 2022. PMID: 35413689. View sourceStudy: animal / in-vitroEpitalon reduced oxidative and quality-related damage in aged mouse oocytes cultured in vitro.
[4] Overview of Epitalon-Highly Bioactive Pineal Tetrapeptide with Promising Properties — Araj SK et al., Int J Mol Sci 2025. PMID: 40141333. View sourceStudy: reviewNarrative review summarizing ~25 years of geroprotective, neuroendocrine and antioxidant Epitalon research, largely preclinical.
[5] Peptides and Ageing — Khavinson VKh, Neuro Endocrinol Lett 2002. PMID: 12374906. View sourceStudy: reviewReview by the originating group describing Epitalon/epithalamin effects on lifespan and melatonin rhythms in animal models.

Related peptides

ThymalinLongevity & Anti-Aging HumaninLongevity & Anti-Aging MOTS-cLongevity & Anti-Aging

This article is for educational and research purposes only. Peptides discussed here are not approved for human consumption by the FDA, EMA, or equivalent regulators outside of specific clinical contexts. Always consult a licensed medical professional before any therapeutic use.